Design of a Workflow Generating Novel Broad-Spectrum siRNA Therapeutics Targeting Critical Conserved RNA Elements in the Viral Genome in silico: A Study in Dengue
Overview
Importance: The likelihood of another COVID-19-level pandemic occurring within 100 years is currently predicted to be 17% and is expected to increase to 44% after the next six decades. Emerging pathogens pose major threats to global health due to their ability to cause catastrophic pandemics. Traditional drug development, requiring an average of 12-15 years and $879.3 million per pathogen, is insufficient to combat pathogenic outbreaks, as shown by dengue: despite infecting ~100 million people yearly and being endemic to >100 countries, dengue still lacks universal treatments. Design: The bioinformatics workflow developed in this study uniquely produces siRNA therapeutics by targeting conserved cis-acting RNA elements (CREs) in the viral genome. The workflow was tested against dengue’s four distinct serotypes to verify broad-spectrum capabilities. Generated siRNAs were filtered through stability, efficacy, conservancy, and specificity parameters. Molecular docking and dynamics analysis evaluated siRNA interactions with cellular machinery. Results: Three siRNA molecules were identified as promising candidates targeting all dengue serotypes, demonstrating ideal GC content (38.10-42.90%), strong binding free energies (-29.4 to -31.6 kcal/mol), and high predicted efficacy (84.95-92.98%). siRNAs exhibited excellent conservancy across dengue serotypes (90-100%) with minimal off-target interactions (E-values 0.66-2.6). High molecular docking scores (-308.79 to -381.49) and confidence scores (>0.95) confirmed robust interactions with cellular machinery vital for genomic silencing. Applications: This workflow could advance the rapid and flexible design of broad-spectrum antivirals for further wet-lab validation, potentially reducing development times by ~22% and costs by ~39%.
Competition history
- ISEF 2025
Resources
Related projects
JSHS · 2025
Design of a workflow generating novel broad-spectrum siRNA therapeutics targeting critical conserved RNA elements in the viral genome in silico: a study in Dengue
ISEF · 2017
Combating Neurovirulence of Zika and Flavivirus Epidemics Using In Silico Phylogenetic Analysis and RNAi Gene Silencing
ISEF · 2022
In silico Analysis of Small Molecules With Possible SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibiting Properties and Their Therapeutic Potential
ISEF · 2024
Atomically Yours: Novel DeepGraphDTI Takes Fight Against Future Pandemics to the Next Level
ISEF · 2026
De novo Design of Broadly Neutralizing Antibodies for Rapidly Evolving Pathogens
JSHS · 2022
Identifying Promising Antiviral Drug Candidates Against SARS-CoV-2 Using Computational Drug Repurposing Methodology
ISEF · 2021
In-silico Prediction of Desoxyhavannahine as a Potential Novel Inhibitor of SARS-COV-2 with Minimal Side Effects
ISEF · 2021
Computer-Based miRNA Predictions to Inhibit SARS-Cov-2 Replication
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair